906 followers
New article: Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer https://t.co/GaLheEc2UL #lungcancer #oncology https://t.co/OqYZtpQsa4
New article: Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer https://t.co/GaLheEc2UL #lungcancer #oncology https://t.co/OqYZtpQsa4
RT @FrontPharmacol: New Research: Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chi…
New Research: Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer https://t.co/z3StoHJLcO #pharmacology